Evidence map›Paper›PMID 41811078›Full record

ArticleAcademic emergency medicine : official journal of the Society for Academic Emergency Medicine2026

"Talk About It!" Shared Decision-Making for Methadone and Buprenorphine Initiation: Development and Preliminary Evaluation of a Conversation Aid via Community-Based Participatory Research.

Elizabeth M Schoenfeld, William E Soares, Abigail L Girardin, Caty Simon, Natalie Strokes, Naomi Lauren, Carol Sánchez Santana, Samantha A Beck, Lauren M Westafer

Abstract read
In one paragraph

Article in Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. A Team Approach to Patient-Centered Communication in the Emergency Department.Academic emergency medicine : official journal of the Society for Academic Emergency Medicine · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Elizabeth M SchoenfeldDepartment of Emergency Medicine, UMass Chan Medical School-Baystate, Springfield, Massachusetts, USA.
William E SoaresDepartment of Emergency Medicine, UMass Chan Medical School-Baystate, Springfield, Massachusetts, USA.
Abigail L GirardinDepartment of Emergency Medicine, UMass Chan Medical School-Baystate, Springfield, Massachusetts, USA.
Caty SimonUrban Survivors Union, Greensboro, North Carolina, USA.
Natalie StrokesDepartment of Emergency Medicine, UMass Chan Medical School-Baystate, Springfield, Massachusetts, USA.
Naomi LaurenWhose Corner Is It Anyway, Holyoke, Massachusetts, USA.
Carol Sánchez SantanaSan Juan Bautista School of Medicine, Caguas, Puerto Rico, USA.
Samantha A BeckUMass Chan Medical School, Worcester, Massachusetts, USA.
Lauren M WestaferDepartment of Emergency Medicine, UMass Chan Medical School-Baystate, Springfield, Massachusetts, USA.

Funding

De-Implementation of Low Value Imaging in Pulmonary Embolism (DELVE PE)K23HL155895 · NHLBI · BAYSTATE MEDICAL CENTER, INC. · PI WESTAFER, LAUREN · 2021 to 2025
$872k
Conversations can save lives: TALKing About Buprenorphine & methadone for Opioid Use Treatment Initiation (TALK ABOUT)R34DA058199 · NIDA · BAYSTATE MEDICAL CENTER, INC. · PI SCHOENFELD, ELIZABETH MAE · 2023 to 2025
$720k
NHLBI NIH HHS 5K23HL155895NHLBI NIH HHS K23 HL155895NIDA NIH HHS R34 DA058199NIDA NIH HHS R34DA058199
6 · The paper itself

Abstract

objectivesAlthough robust evidence exists supporting opioid agonist treatment (OAT) as the best currently available treatment for opioid use disorder (OUD), many barriers prevent widespread access to the two most efficacious forms of OAT, buprenorphine and methadone. We sought to address interpersonal and knowledge-related barriers to OAT implementation by facilitating shared decision-making in the context of ED care. The objective of this study was to refine and evaluate an OUD treatment conversation aid in partnership with people with lived experience (PWLE).

methodsWe combined community-based participatory research principles, decision aid development guidelines, and qualitative methods. Via the longitudinal involvement of a multi-stakeholder Steering Committee (SC), interviews, and focus groups, we iteratively refined and evaluated a conversation aid, Talk About It (TAI). We performed beta-testing with ED patients with untreated OUD and clinicians and evaluated the aid via validated implementation measures of acceptability, appropriateness, and feasibility (3 scales, 4 questions each, range 1-5). Finally, TAI was translated into Spanish and Spanish-speaking patients and clinicians gave feedback.

resultsOver 100 people engaged in the refinement and evaluation of TAI. Of the 75 patient and community member participants, about half (34) reported using opioids within the past week. Refinements to TAI included changing content, simplifying language, and adding quotes, faces, and local resources. Validated acceptability, appropriateness, and feasibility measures demonstrated increasing scores. ED patients with untreated OUD gave the final version mean scores of 4.72, 4.70, and 4.67, respectively (range 1-5), indicating high agreement with implementation potential.

conclusionTAI's content and style were designed, refined, and approved by PWLE, ED clinicians, and addiction experts. Further testing will be needed to measure effectiveness.

Indexed as

Analgesics, OpioidBuprenorphineDecision Making, SharedMethadoneOpiate Substitution TreatmentOpioid-Related DisordersAdultCommunity-Based Participatory ResearchFemaleFocus GroupsHumansMaleMiddle AgedAnalgesics, OpioidBuprenorphineMethadone

Identifiers

PMID41811078
PMCPMC13196692

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.